A Novel Fusion Antibody Exhibits Antiangiogenic Activity and Stimulates NK Cell-mediated Immune Surveillance Through Fused NKG2D Ligand
2017 · Journal of Immunotherapy · 9 citations
https://doi.org/10.1097/cji.0000000000000157
M
Mingying Tang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
324
Citations
9
h-index
9
i10-index
Mingying Tang is an academic researcher. The author has contributed to research in topics: Immune Cell Function and Interaction & RNA modifications and cancer & CAR-T cell therapy research. The author has an h-index of 9, co-authored 14 publications.
Papers by this author
worksmiR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.9968876.v2
miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.9968876.v1
miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.9968876
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat